RedHill Stock Skyrockets 127% on a Five-Year FDA Exclusivity Grant

seekingalpha2023-11-27

U.S.-listed shares of RedHill Biopharma on Monday nearly doubled in value ahead of the opening bell, after the company got a regulatory grant of five-year market exclusivity for its drug Talicia.RDHL ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2386118799?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-11-27 23:12","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2386118799","market":"us","top_or_hot":-1,"title":"RedHill Stock Skyrockets 127% on a Five-Year FDA Exclusivity Grant","media":"seekingalpha","content":"<div>\n<p>U.S.-listed shares of RedHill Biopharma on Monday nearly doubled in value ahead of the opening bell, after the company got a regulatory grant of five-year market exclusivity for its drug Talicia.RDHL ...</p>\n\n<a href=\"https://seekingalpha.com/news/4040264-redhill-stock-nearly-doubles-in-value-pre-market-on-a-five-year-fda-exclusivity-grant\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RedHill Stock Skyrockets 127% on a Five-Year FDA Exclusivity Grant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRedHill Stock Skyrockets 127% on a Five-Year FDA Exclusivity Grant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-27 23:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4040264-redhill-stock-nearly-doubles-in-value-pre-market-on-a-five-year-fda-exclusivity-grant><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S.-listed shares of RedHill Biopharma on Monday nearly doubled in value ahead of the opening bell, after the company got a regulatory grant of five-year market exclusivity for its drug Talicia.RDHL ...</p>\n\n<a href=\"https://seekingalpha.com/news/4040264-redhill-stock-nearly-doubles-in-value-pre-market-on-a-five-year-fda-exclusivity-grant\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RDHL","symbol_name":"Redhill Biopharma Ltd","start_time":0,"source_url":"https://seekingalpha.com/news/4040264-redhill-stock-nearly-doubles-in-value-pre-market-on-a-five-year-fda-exclusivity-grant","article_id":"2386118799","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2386118799","pubTimestamp":1701097968,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"U.S.-listed shares of RedHill Biopharma  on Monday nearly doubled in value ahead of the opening bell, after the company got a regulatory grant of five-year market exclusivity for its drug Talicia. RDHL stock soared 96.5% to $0.62 in pre-market trading. The U.S. Food and Drug Administration  granted five years' market exclusivity for Talicia under the Generating Antibiotic Incentives Now Act Qualified Infectious Disease Product designation, RDHL said in a statement.  The grant in on top of the three years' exclusivity which came with the approval of Talicia. Talicia is indicated for the treatment of Helicobacter pylori infection in adults, which is a common type of bacterial infection that attacks the lining in the stomach. \"Talicia is protected by its broad intellectual property suite to 2034,\" Redhill Biopharma  added.   More on RedHill  Financial information for RedHill RedHill Biopharma receives approval to transfer its listing to the Nasdaq Capital Market","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RDHL":"Redhill Biopharma Ltd"},"translate_title":"红山股票在FDA五年独家授权下暴涨127%","themeId":"c5bbfdf5f7964880af97c1d6f417052c","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RDHL":1},"content_text":"U.S.-listed shares of RedHill Biopharma on Monday nearly doubled in value ahead of the opening bell, after the company got a regulatory grant of five-year market exclusivity for its drug Talicia.RDHL stock soared 127.45% to $0.72 in pre-market trading.The U.S. Food and Drug Administration (FDA) granted five years' market exclusivity for Talicia under the Generating Antibiotic Incentives Now Act Qualified Infectious Disease Product designation, RDHL said in a statement.The grant in on top of the three years' exclusivity which came with the approval of Talicia.Talicia is indicated for the treatment of Helicobacter pylori infection in adults, which is a common type of bacterial infection that attacks the lining in the stomach.\"Talicia is protected by its broad intellectual property suite to 2034,\" Redhill Biopharma (RDHL) added.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":11,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2386118799"}